Covis Pharma (18 Drug Portfolio) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Covis Pharma (18 Drug Portfolio) General Information

Description

18 drug portfolio of Covis Pharma. The portfolio includes branded pharmaceuticals, injectables and authorized generics that address life threatening and other serious medical conditions in various therapeutic areas including cardiovascular, central nervous system, oncology and acute care markets.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Acquirer
Corporate Office
  • 1513 Walnut Street
  • Suite 270
  • Cary, NC 27511
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Covis Pharma (18 Drug Portfolio) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Covis Pharma (18 Drug Portfolio)‘s full profile, request access.

Request a free trial

Covis Pharma (18 Drug Portfolio) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Covis Pharma (18 Drug Portfolio)‘s full profile, request access.

Request a free trial

Covis Pharma (18 Drug Portfolio) FAQs

  • Where is Covis Pharma (18 Drug Portfolio) headquartered?

    Covis Pharma (18 Drug Portfolio) is headquartered in Cary, NC.

  • What industry is Covis Pharma (18 Drug Portfolio) in?

    Covis Pharma (18 Drug Portfolio)’s primary industry is Buildings and Property.

  • Is Covis Pharma (18 Drug Portfolio) a private or public company?

    Covis Pharma (18 Drug Portfolio) is a Private company.

  • What is the current valuation of Covis Pharma (18 Drug Portfolio)?

    The current valuation of Covis Pharma (18 Drug Portfolio) is 00.00.

  • What is Covis Pharma (18 Drug Portfolio)’s current revenue?

    The current revenue for Covis Pharma (18 Drug Portfolio) is 000000.

  • Who are Covis Pharma (18 Drug Portfolio)’s investors?

    Covis Pharma has invested in Covis Pharma (18 Drug Portfolio).

  • When was Covis Pharma (18 Drug Portfolio) acquired?

    Covis Pharma (18 Drug Portfolio) was acquired on 21-Apr-2015.

  • Who acquired Covis Pharma (18 Drug Portfolio)?

    Covis Pharma (18 Drug Portfolio) was acquired by Advanz Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »